spire healthcare finance limited
spire healthcare finance limited Company Information
Company Number
09080180
Next Accounts
Sep 2025
Industry
Activities of head offices
Shareholders
spire healthcare group plc
Group Structure
View All
Contact
Registered Address
3 dorset rise, london, EC4Y 8EN
Website
www.spirehealthcare.comspire healthcare finance limited Estimated Valuation
Pomanda estimates the enterprise value of SPIRE HEALTHCARE FINANCE LIMITED at £0 based on a Turnover of £0 and 0.5x industry multiple (adjusted for size and gross margin).
spire healthcare finance limited Estimated Valuation
Pomanda estimates the enterprise value of SPIRE HEALTHCARE FINANCE LIMITED at £0 based on an EBITDA of £0 and a 3.74x industry multiple (adjusted for size and gross margin).
spire healthcare finance limited Estimated Valuation
Pomanda estimates the enterprise value of SPIRE HEALTHCARE FINANCE LIMITED at £4.5b based on Net Assets of £2.1b and 2.13x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Spire Healthcare Finance Limited Overview
Spire Healthcare Finance Limited is a live company located in london, EC4Y 8EN with a Companies House number of 09080180. It operates in the activities of head offices sector, SIC Code 70100. Founded in June 2014, it's largest shareholder is spire healthcare group plc with a 100% stake. Spire Healthcare Finance Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Spire Healthcare Finance Limited Health Check
Pomanda's financial health check has awarded Spire Healthcare Finance Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 2 areas for improvement. Company Health Check FAQs
1 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Spire Healthcare Finance Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Spire Healthcare Finance Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Spire Healthcare Finance Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Spire Healthcare Finance Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (111)
- Spire Healthcare Finance Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Spire Healthcare Finance Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Spire Healthcare Finance Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Spire Healthcare Finance Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Spire Healthcare Finance Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Spire Healthcare Finance Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (15 weeks)
- - Spire Healthcare Finance Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 28.1%, this is a lower level of debt than the average (55.4%)
- - Spire Healthcare Finance Limited
- - Industry AVG
SPIRE HEALTHCARE FINANCE LIMITED financials
Spire Healthcare Finance Limited's latest turnover from December 2023 is 0 and the company has net assets of £2.1 billion. According to their latest financial statements, we estimate that Spire Healthcare Finance Limited has 1 employee and maintains cash reserves of £100 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Admin Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19,000 | |
| Interest Payable | 50,517,000 | 31,475,000 | 26,072,000 | 24,060,000 | 24,758,000 | 13,135,000 | 14,443,000 | 13,791,000 | 13,368,000 | 6,051,000 |
| Interest Receivable | 95,557,000 | 77,797,000 | 47,550,000 | 4,050,000 | 5,081,000 | 818,000 | 1,935,000 | 940,000 | 0 | 47,000 |
| Pre-Tax Profit | 97,169,000 | 93,201,000 | 638,376,000 | 26,524,000 | 25,993,000 | 31,978,000 | 30,317,000 | 30,781,000 | 241,695,000 | 30,325,000 |
| Tax | -10,584,000 | -8,801,000 | -4,081,000 | 3,085,000 | 3,739,000 | 1,700,000 | 2,408,000 | 2,570,000 | 2,707,000 | 1,295,000 |
| Profit After Tax | 86,585,000 | 84,400,000 | 634,295,000 | 29,609,000 | 29,732,000 | 33,678,000 | 32,725,000 | 33,351,000 | 244,402,000 | 31,620,000 |
| Dividends Paid | 52,129,000 | 46,879,000 | 43,399,000 | 46,534,000 | 45,670,000 | 44,295,000 | 42,825,000 | 43,632,000 | 42,344,000 | 36,348,000 |
| Retained Profit | 34,456,000 | 37,521,000 | 590,896,000 | -16,925,000 | -15,938,000 | -10,617,000 | -10,100,000 | -10,281,000 | 202,058,000 | -4,728,000 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number Of Employees | ||||||||||
| EBITDA* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 1,980,808,000 | 1,980,808,000 | 1,980,808,000 | 1,459,646,000 | 1,459,646,000 | 1,459,646,000 | 1,459,646,000 | 1,459,646,000 | 1,459,646,000 | 1,246,927,000 |
| Debtors (Due After 1 year) | 925,445,000 | 838,698,000 | 756,733,000 | 158,914,000 | 154,938,000 | 150,147,000 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 2,906,253,000 | 2,819,506,000 | 2,737,541,000 | 1,618,560,000 | 1,614,584,000 | 1,609,793,000 | 1,459,646,000 | 1,459,646,000 | 1,459,646,000 | 1,246,927,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 60,206,000 | 30,229,000 | 23,540,000 | 3,004,000 | 2,977,000 | 18,861,000 | 31,870,000 | 59,337,000 | 0 | 5,552,000 |
| Misc Debtors | 0 | 3,643,000 | 5,114,000 | 9,195,000 | 6,079,000 | 2,340,000 | 2,408,000 | 2,570,000 | 2,707,000 | 26,000 |
| Cash | 100,000 | 31,000 | 24,000 | 167,000 | 88,000 | 171,000 | 12,000 | 9,000 | 22,000 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 60,306,000 | 33,903,000 | 28,678,000 | 12,366,000 | 9,144,000 | 21,372,000 | 34,290,000 | 61,916,000 | 2,729,000 | 5,578,000 |
| total assets | 2,966,559,000 | 2,853,409,000 | 2,766,219,000 | 1,630,926,000 | 1,623,728,000 | 1,631,165,000 | 1,493,936,000 | 1,521,562,000 | 1,462,375,000 | 1,252,505,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 3,292,000 | 2,934,000 | 5,661,000 | 2,222,000 | 1,668,000 | 1,472,000 | 795,000 | 783,000 | 985,000 | 1,167,000 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 327,122,000 | 255,991,000 | 118,175,000 | 89,861,000 | 69,784,000 | 66,409,000 | 64,625,000 | 83,281,000 | 14,729,000 | 7,853,000 |
| other short term finances | 0 | 0 | 677,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 686,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 330,414,000 | 259,611,000 | 124,513,000 | 92,083,000 | 71,452,000 | 67,881,000 | 65,420,000 | 84,064,000 | 15,714,000 | 9,020,000 |
| loans | 501,734,000 | 489,634,000 | 584,392,000 | 581,556,000 | 576,575,000 | 569,637,000 | 424,348,000 | 423,230,000 | 422,112,000 | 420,994,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 2,167,000 | 1,815,000 | 171,000 | 0 | 254,000 | 640,000 | 0 | 0 | 0 | 0 |
| total long term liabilities | 503,901,000 | 491,449,000 | 584,563,000 | 581,556,000 | 576,829,000 | 570,277,000 | 424,348,000 | 423,230,000 | 422,112,000 | 420,994,000 |
| total liabilities | 834,315,000 | 751,060,000 | 709,076,000 | 673,639,000 | 648,281,000 | 638,158,000 | 489,768,000 | 507,294,000 | 437,826,000 | 430,014,000 |
| net assets | 2,132,244,000 | 2,102,349,000 | 2,057,143,000 | 957,287,000 | 975,447,000 | 993,007,000 | 1,004,168,000 | 1,014,268,000 | 1,024,549,000 | 822,491,000 |
| total shareholders funds | 2,132,244,000 | 2,102,349,000 | 2,057,143,000 | 957,287,000 | 975,447,000 | 993,007,000 | 1,004,168,000 | 1,014,268,000 | 1,024,549,000 | 822,491,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19,000 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -10,584,000 | -8,801,000 | -4,081,000 | 3,085,000 | 3,739,000 | 1,700,000 | 2,408,000 | 2,570,000 | 2,707,000 | 1,295,000 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 113,081,000 | 87,183,000 | 614,274,000 | 7,119,000 | -7,354,000 | 137,070,000 | -27,629,000 | 59,200,000 | -2,871,000 | 5,578,000 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | -686,000 | 686,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 352,000 | 1,644,000 | 171,000 | -254,000 | -386,000 | 640,000 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -123,999,000 | -93,654,000 | -618,184,000 | 10,707,000 | -134,730,000 | 30,037,000 | -56,630,000 | 5,578,000 | -4,302,000 | |
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 521,162,000 | 0 | 0 | 0 | 0 | 0 | 212,719,000 | 1,246,927,000 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 358,000 | -2,727,000 | 3,439,000 | 554,000 | 196,000 | 677,000 | 12,000 | -202,000 | -182,000 | 1,167,000 |
| Group/Directors Accounts | 71,131,000 | 137,816,000 | 28,314,000 | 20,077,000 | 3,375,000 | 1,784,000 | -18,656,000 | 68,552,000 | 6,876,000 | 7,853,000 |
| Other Short Term Loans | 0 | -677,000 | 677,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 12,100,000 | -94,758,000 | 2,836,000 | 4,981,000 | 6,938,000 | 145,289,000 | 1,118,000 | 1,118,000 | 1,118,000 | 420,994,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | 45,040,000 | 46,322,000 | 21,478,000 | -20,010,000 | -19,677,000 | -12,317,000 | -12,508,000 | -12,851,000 | -13,368,000 | -6,004,000 |
| cash flow from financing | 124,068,000 | 93,661,000 | 565,704,000 | 4,367,000 | -10,790,000 | 134,889,000 | -30,034,000 | 56,617,000 | -5,556,000 | 1,251,229,000 |
| cash and cash equivalents | ||||||||||
| cash | 69,000 | 7,000 | -143,000 | 79,000 | -83,000 | 159,000 | 3,000 | -13,000 | 22,000 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 69,000 | 7,000 | -143,000 | 79,000 | -83,000 | 159,000 | 3,000 | -13,000 | 22,000 | 0 |
spire healthcare finance limited Credit Report and Business Information
Spire Healthcare Finance Limited Competitor Analysis
Perform a competitor analysis for spire healthcare finance limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in EC4Y area or any other competitors across 12 key performance metrics.
spire healthcare finance limited Ownership
SPIRE HEALTHCARE FINANCE LIMITED group structure
Spire Healthcare Finance Limited has 4 subsidiary companies.
Ultimate parent company
1 parent
SPIRE HEALTHCARE FINANCE LIMITED
09080180
4 subsidiaries
spire healthcare finance limited directors
Spire Healthcare Finance Limited currently has 4 directors. The longest serving directors include Mr Peter Corfield (Mar 2018) and Harbant Samra (Mar 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Peter Corfield | 53 years | Mar 2018 | - | Director | |
| Harbant Samra | 51 years | Mar 2022 | - | Director | |
| Mr Harbant Samra | 45 years | Mar 2022 | - | Director | |
| Mr Mantraraj Budhdev | 38 years | May 2024 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
2.1b
+0.01%
total assets
3b
+0.04%
cash
100k
+2.23%
net assets
Total assets minus all liabilities
spire healthcare finance limited company details
company number
09080180
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
June 2014
age
11
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
ERNST & YOUNG LLP
address
3 dorset rise, london, EC4Y 8EN
Bank
-
Legal Advisor
-
spire healthcare finance limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to spire healthcare finance limited. Currently there are 3 open charges and 0 have been satisfied in the past.
spire healthcare finance limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SPIRE HEALTHCARE FINANCE LIMITED. This can take several minutes, an email will notify you when this has completed.
spire healthcare finance limited Companies House Filings - See Documents
| date | description | view/download |
|---|
